[CUE] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
14-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 18.36%
YoY- 16.27%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 1,382 187 151 68 26 1,000 8,254 -69.72%
PBT -13,185 -13,109 -14,592 -10,955 -13,208 -14,255 -7,890 40.95%
Tax 564 99 -138 -76 118 17 495 9.11%
NP -13,185 -13,208 -14,454 -10,879 -13,326 -14,272 -8,384 35.34%
Tax Rate - - - - - - - -
Total Cost 14,567 13,395 14,605 10,947 13,352 15,272 16,639 -8.50%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -954.05 -7,063.10 -9,557.79 -15,998.53 -51,253.85 -1,427.20 -101.57 347.01%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.29 -0.30 -0.37 -0.31 -0.38 -0.44 -0.27 4.89%
EPS Diluted -0.29 -0.30 -0.37 -0.31 -0.38 -0.44 -0.27 4.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.